AXS Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-23,273
| Closed | -$1.32M | – | 209 |
|
|
2024
Q4 | $1.32M | Buy |
+23,273
| New | +$1.32M | 0.37% | 122 |
|
|
2024
Q2 | – | Sell |
-24,325
| Closed | -$1.32M | – | 231 |
|
|
2024
Q1 | $1.32M | Sell |
24,325
-973
| -4% | -$52.8K | 0.32% | 115 |
|
|
2023
Q4 | $1.3M | Buy |
25,298
+5,088
| +25% | +$261K | 0.31% | 129 |
|
|
2023
Q3 | $1.17M | Buy |
20,210
+1,763
| +10% | +$102K | 0.3% | 121 |
|
|
2023
Q2 | $1.18M | Buy |
18,447
+1,425
| +8% | +$91.1K | 0.31% | 127 |
|
|
2023
Q1 | $1.18M | Buy |
17,022
+2,369
| +16% | +$164K | 0.39% | 93 |
|
|
2022
Q4 | $1.05M | Buy |
14,653
+181
| +1% | +$13K | 0.38% | 105 |
|
|
2022
Q3 | $1.03M | Buy |
14,472
+781
| +6% | +$55.5K | 0.4% | 74 |
|
|
2022
Q2 | $1.05M | Buy |
+13,691
| New | +$1.05M | 0.37% | 73 |
|